WBO:BNTX (Germany)  
BioNTech SE logo

BioNTech SE

€ 136.95 (+1.11%) Sep 27
P/E:
2.47
P/B:
1.78
Market Cap:
€ 32.86B ($ 32.00B)
Enterprise V:
€ 23.77B ($ 23.14B)
Volume:
25.00
Avg Vol (2M):
124.00
Also Trade In:
Volume:
25.00
Market Cap €:
32.86B
Market Cap $:
32.00B
PE Ratio:
2.47
Avg Vol (2-Month):
124.00
Enterprise Value €:
23.77B
Enterprise Value $:
23.14B
PB Ratio:
1.78
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Description
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and small-molecule immunomodulators. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Comirnaty (COVID-19 vaccine) is its first commercialized product.
Name Current Vs Industry Vs History
Cash-To-Debt 39.08
Equity-to-Asset 0.8
Debt-to-Equity 0.01
Debt-to-EBITDA 0.01
Interest Coverage 1116.85
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 9.89
Distress
Grey
Safe
Beneish M-Score -1.28
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 50.73
9-Day RSI 43.02
14-Day RSI 41.64
6-1 Month Momentum % -0.85
12-1 Month Momentum % -48.59

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.15
Quick Ratio 5.06
Cash Ratio 2.38
Days Inventory 29.53
Days Sales Outstanding 183.69
Days Payable 16.05

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -2.3

Financials (Next Earnings Date:2022-11-07)

WBO:BNTX's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 21,190.9
EPS (TTM) (€) 46.985
Beta 0
Volatility % 58.73
14-Day RSI 41.64
14-Day ATR (€) 3.663
20-Day SMA (€) 141.8325
12-1 Month Momentum % -48.59
52-Week Range (€) 113 - 330
Shares Outstanding (Mil) 242.69

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

BioNTech SE Filings

Document Form Filing Date
No Filing Data

BioNTech SE Analysis

Share your research